Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Views 3,917
Citations 0
In This Issue of JAMA
April 16, 2014


Author Affiliations

Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA. 2014;311(15):1475-1477. doi:10.1001/jama.2013.279444

Deployment of valves in transcatheter aortic valve replacement (TAVR) requires a balloon-expandable or self-expandable system. Abdel-Wahab and colleagues assessed the comparative performance of these 2 systems in a randomized trial that enrolled 241 patients scheduled to undergo TAVR. The authors report that the balloon-expandable prosthesis resulted in a greater rate of device success—a composite of successful vascular access, device deployment and retrieval of the delivery system; correct device positioning; performance without moderate or severe regurgitation; and only 1 valve implanted. In an Editorial, Tuzcu and Kapadia discuss factors to consider when choosing a valve for TAVR.


Author Audio Interview

In a multicenter randomized placebo-controlled trial that enrolled 7226 hospitalized patients with type 2 diabetes and acute coronary syndrome (ACS), Lincoff and colleagues assessed whether the addition of aleglitazar—a drug with insulin-sensitizing and glucose-lowering actions and favorable effects on lipid profiles—to standard medical therapy would reduce cardiovascular morbidity and mortality. The authors report that despite favorable metabolic effects, aleglitazar had no beneficial effect on cardiovascular morbidity or mortality.

Metformin treatment is associated with improved outcomes after ST-segment elevation myocardial infarction (STEMI) in patients with diabetes. In animal studies, metformin preserves left ventricular (LV) function. In a randomized placebo-controlled trial that enrolled 380 patients without diabetes who underwent primary percutaneous coronary intervention for STEMI, Lexis and colleagues found that compared with placebo, use of metformin (500 mg twice daily for 4 months) did not result in improved LV ejection fraction assessed 4 months after infarction.

In a systematic review and meta-analysis of data from 38 cohort studies, Aune and colleagues assessed the relationship between maternal body mass index (BMI) and risk of fetal death, stillbirth, and neonatal, perinatal, and infant death. The authors found that even modest increases in maternal BMI were associated with increased risk of these outcomes, with the greatest risk observed in the category of severe obesity.

Clinical Review & Education

Fibromyalgia—characterized by widespread pain and often accompanied by fatigue, memory problems, and sleep and mood disturbances—has an estimated prevalence of 2% to 8%. In this JAMA Clinical Crossroads article, Clauw discusses the epidemiology, pathophysiology, diagnosis, and evidence-based pharmacologic and nonpharmacologic treatment of this disorder.

Continuing Medical Education, Author Video Interview

High-frequency hearing loss—typically noise-related and preventable—is increasing among adolescents. A study in JAMAOtolaryngologyHead and Neck Surgery reported results of a survey to assess parental knowledge of and perspectives on adolescent hearing loss that found few parents thought their adolescent was at risk and a majority had not discussed noise-related hearing loss with their child. In this From the JAMA Network article, Kesser discusses parent education as an approach to preventing noise-induced hearing loss in children.

A 60-year-old man presents with a painless nodular mass on the hard palate. He reports slow enlargement over 20 years’ time, with a noticeable increase recently. What would you do next?